WO1997046683A3 - Polynucleotides encoding secreted proteins - Google Patents
Polynucleotides encoding secreted proteins Download PDFInfo
- Publication number
- WO1997046683A3 WO1997046683A3 PCT/US1997/009878 US9709878W WO9746683A3 WO 1997046683 A3 WO1997046683 A3 WO 1997046683A3 US 9709878 W US9709878 W US 9709878W WO 9746683 A3 WO9746683 A3 WO 9746683A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- human
- secreted proteins
- encoding secreted
- polynucleotides encoding
- clones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10500884A JP2001501455A (en) | 1996-06-07 | 1997-06-06 | Polynucleotides encoding secreted proteins |
AU33804/97A AU3380497A (en) | 1996-06-07 | 1997-06-06 | Polynucleotide encoding secreted proteins |
EP97929838A EP0910638A2 (en) | 1996-06-07 | 1997-06-06 | Polynucleotide encoding secreted proteins |
CA002256522A CA2256522A1 (en) | 1996-06-07 | 1997-06-06 | Polynucleotides encoding secreted proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65922496A | 1996-06-07 | 1996-06-07 | |
US08/659,224 | 1996-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997046683A2 WO1997046683A2 (en) | 1997-12-11 |
WO1997046683A3 true WO1997046683A3 (en) | 1998-05-07 |
Family
ID=24644568
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/009878 WO1997046683A2 (en) | 1996-06-07 | 1997-06-06 | Polynucleotides encoding secreted proteins |
PCT/US1997/009865 WO1997046682A2 (en) | 1996-06-07 | 1997-06-06 | Polynucleotides from human adult pbmc encoding secreted proteins |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/009865 WO1997046682A2 (en) | 1996-06-07 | 1997-06-06 | Polynucleotides from human adult pbmc encoding secreted proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0910638A2 (en) |
JP (2) | JP2001501455A (en) |
AU (2) | AU3568697A (en) |
CA (1) | CA2256522A1 (en) |
WO (2) | WO1997046683A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005509B1 (en) | 1995-02-17 | 2006-02-28 | Incyte Corporation | Chemokine PANEC-1 polynucleotides and compositions and methods related thereto |
US7265201B1 (en) | 1995-06-23 | 2007-09-04 | Millennium Pharmaceuticals, Inc. | Human chemotactic cytokine |
AU2451199A (en) * | 1998-01-07 | 1999-07-26 | Human Genome Sciences, Inc. | 36 human secreted proteins |
US7173005B2 (en) | 1998-09-02 | 2007-02-06 | Antyra Inc. | Insulin and IGF-1 receptor agonists and antagonists |
US6875741B2 (en) | 1998-09-02 | 2005-04-05 | Renuka Pillutla | Insulin and IGF-1 receptor agonists and antagonists |
JP2004512010A (en) * | 2000-03-29 | 2004-04-22 | ディージーアイ・バイオテクノロジーズ・エル・エル・シー | Insulin and IGF-1 receptor agonists and antagonists |
CN111334469A (en) * | 2020-03-27 | 2020-06-26 | 郑州鲲鹏健康科技有限公司 | PBMC (peripheral blood mononuclear cell) in-vitro 3D (three-dimensional) methylcellulose agarose hydrogel culture medium and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
-
1997
- 1997-06-06 JP JP10500884A patent/JP2001501455A/en active Pending
- 1997-06-06 CA CA002256522A patent/CA2256522A1/en not_active Abandoned
- 1997-06-06 JP JP10500876A patent/JP2000515726A/en active Pending
- 1997-06-06 WO PCT/US1997/009878 patent/WO1997046683A2/en not_active Application Discontinuation
- 1997-06-06 WO PCT/US1997/009865 patent/WO1997046682A2/en not_active Application Discontinuation
- 1997-06-06 AU AU35686/97A patent/AU3568697A/en not_active Abandoned
- 1997-06-06 AU AU33804/97A patent/AU3380497A/en not_active Abandoned
- 1997-06-06 EP EP97929838A patent/EP0910638A2/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
Non-Patent Citations (8)
Title |
---|
CALLARD R E ET AL: "AIMS OF THE BOOK", CYTOKINE FACTSBOOK, 1994, CALLARD R E;GEARING A J H, pages 2/3, 31 - 38, 64/65, 75/76, 97/98, 148 - 151, 252/253, XP002039160 * |
ENG MONG LIM ET AL: "IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS DNA SEQUENCES ENCODING EXPORTED PROTEINS BY USING PHOA GENE FUSIONS", JOURNAL OF BACTERIOLOGY, vol. 177, no. 1, 1 January 1995 (1995-01-01), pages 59 - 65, XP000560419 * |
J. NATHANS: "69C1 human retina cDNA Tsp509I-cleaved sublibrary Homo sapiens cDNA not directional", EMBL DATABASE ENTRY HSW22546, ACCESSION NUMBER W22546, 9 May 1996 (1996-05-09), XP002046017 * |
JACOBS K ET AL: "A NOVEL METHOD FOR ISOLATING EUKARYOTIC CDNA CLONES ENCODING SECRETED PROTEINS", JOURNAL OF CELLULAR BIOCHEMISTRY - SUPPLEMENT, vol. 21A, 10 March 1995 (1995-03-10), pages 19, XP002027246 * |
K. A. JACOBS ET AL: "A genetic selection for isolating cDNAs encoding secreted proteins", GENE., vol. 198, 1 October 1997 (1997-10-01), AMSTERDAM NL, pages 289 - 296, XP002045919 * |
L. HILLIER ET AL: "The WashU-Merck EST project. zo29g02.r1 stratagene colon(#937204) Homo sapiens cDNA clone 588338 5'", EMBL DATABASE ENTRY HSAA51630 , ACCESSION NUMBER AA151630, 15 December 1996 (1996-12-15), XP002046018 * |
M. YOKOYAMA-KOBAYASHI ET AL: "A signal sequence detection system using secreted protease activity as an indicator", GENE., vol. 163, 1995, AMSTERDAM NL, pages 193 - 196, XP002046435 * |
TASHIRO K ET AL: "SIGNAL SEQUENCE TRAP: A CLONING STRATEGY FOR SECRETED PROTEINS AND TYPE I MEMBRANE PROTEINS", SCIENCE, vol. 261, 30 July 1993 (1993-07-30), pages 600 - 603, XP000673204 * |
Also Published As
Publication number | Publication date |
---|---|
CA2256522A1 (en) | 1997-12-11 |
WO1997046682A2 (en) | 1997-12-11 |
JP2000515726A (en) | 2000-11-28 |
WO1997046682A3 (en) | 1998-03-12 |
AU3380497A (en) | 1998-01-05 |
WO1997046683A2 (en) | 1997-12-11 |
EP0910638A2 (en) | 1999-04-28 |
JP2001501455A (en) | 2001-02-06 |
AU3568697A (en) | 1998-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999008649A3 (en) | Foaming skin cream | |
HK1032759A1 (en) | Apparatus for restoring the balance of the human body. | |
WO1994012645A3 (en) | Cdna clone for human inducible nitric oxyde synthase and process for preparing same | |
WO1998058052A3 (en) | Disease associated protein kinases | |
ZA9711090B (en) | Process for the preparation of hydrocarbons. | |
WO2000021988A3 (en) | Human ankyrin family protein | |
WO1999058692A3 (en) | Human apoptosis associated proteins | |
WO1997048801A3 (en) | Polynucleotides encoding secreted proteins | |
WO1997046683A3 (en) | Polynucleotides encoding secreted proteins | |
WO2001016377A3 (en) | Diagnostics and therapeutics for osteoporosis | |
WO2001077291A3 (en) | Polynucleotides encoding novel secreted proteins | |
WO2001077289A3 (en) | Polynucleotides encoding novel secreted proteins | |
EP0731111A3 (en) | Microporous crumbs of hydrogenated block copolymers and process for producing the same | |
WO1999024587A3 (en) | Human phospholipase a2 protein and dna encoding it | |
WO1997048799A3 (en) | Polynucleotides from human fetal brain encoding secreted proteins | |
WO2001077288A3 (en) | Polynucleotides encoding novel secreted proteins | |
WO1999031128A3 (en) | Human tumor necrosis factor-r2-like proteins | |
WO2000031263A3 (en) | Gtpase associated proteins | |
HK1038510A1 (en) | Use of neurotrophic factor stimulators for the treamtent of ophthalmic neurodegenerative diseases. | |
WO1997040069A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO2001077290A3 (en) | Polynucleotides encoding novel secreted proteins | |
WO1999031225A3 (en) | Human phosphatases | |
WO1998024896A3 (en) | Muteins of obese protein | |
WO1998059041A3 (en) | Disease related nucleotide kinases | |
AU3382997A (en) | Polynucleotides encoding secreted proteins from human dendritic cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2256522 Country of ref document: CA Ref country code: CA Ref document number: 2256522 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997929838 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997929838 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997929838 Country of ref document: EP |